# Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis

> **NCT06011083** · NA · COMPLETED · sponsor: **Assiut University** · enrollment: 40 (actual)

## Conditions studied

- Psoriasis Vulgaris
- Fractional CO2 Laser

## Interventions

- **DRUG:** Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm
- **DEVICE:** Fractional carbon dioxide (CO2) laser

## Key facts

- **NCT ID:** NCT06011083
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-08-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06011083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06011083, "Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06011083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*